{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:08Z","timestamp":1758971408157,"version":"3.44.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.annder.2011.02.008","type":"journal-article","created":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T03:19:40Z","timestamp":1315019980000},"page":"610-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prise en charge symptomatique de la douleur neuropathique en dermatologie\u00a0: application aux algies postzost\u00e9riennes"],"prefix":"10.1016","volume":"138","author":[{"given":"G.","family":"Bohelay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rafaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Caravias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2011.02.008_bib0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0010","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O\u2019Connor","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","article-title":"Pain, medication use, and health-related quality of life in older persons with post-herpetic neuralgia: results from a population-based survey","volume":"6","author":"Oster","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0020","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jpain.2006.04.013","article-title":"Burden of illness in painful diabetic peripheral neuropathy: the patients\u2019 perspectives","volume":"7","author":"Gore","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: quality of life-impact, costs and cost-effectiveness of therapy","volume":"27","author":"O\u2019Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.annder.2011.02.008_bib0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010\u00a0revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.annder.2011.02.008_bib0035","first-page":"3","article-title":"Chronic neuropathic pain: diagnosis, evaluation and treatment in outpatient services. Guidelines for clinical practice of the French society for the study and treatment of pain","volume":"11","author":"Martinez","year":"2010","journal-title":"Douleurs"},{"key":"10.1016\/j.annder.2011.02.008_bib0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pain.2005.11.015","article-title":"Is CRPS a neuropathic pain syndrome?","volume":"120","author":"J\u00e4nig","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanism of disease: neuropathic pain-a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Prac Neurol"},{"key":"10.1016\/j.annder.2011.02.008_bib0050","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2005.09.006","article-title":"Sodium channels and mechanisms of neuropathic pain","volume":"7","author":"Devor","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jcp.21280","article-title":"Ionic channels and neuropathic pain: physiopathology and applications","volume":"215","author":"Aurilio","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.annder.2011.02.008_bib0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pain.2006.10.034","article-title":"Using screening tools to identify neuropathic pain","volume":"127","author":"Bennett","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0070","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentine, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2011.02.008_bib0090","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful neuropathy. A randomized controlled trial","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2011.02.008_bib0110","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2011.02.008_bib0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomised, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentine in postherpetic neuralgia: a randomized, double-blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-4362.2003.01831.x","article-title":"The role of gabapentine in treating diseases with cutaneous manifestations and pain","volume":"42","author":"Scheinfeld","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.02.008_bib0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-200565010-00011","article-title":"Pregabalin: in the treatment of postherpetic neuralgia","volume":"65","author":"Frampton","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.annder.2011.02.008_bib0145","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.annder.2011.02.008_bib0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01212087","article-title":"Symptomatic treatment of peripheral diabetic neuropathy with carbamezepine (Tegretol): double blind crossover trial","volume":"5","author":"Rull","year":"1969","journal-title":"Diabetologia"},{"key":"10.1016\/j.annder.2011.02.008_bib0155","first-page":"525","article-title":"Nortriptyline-fluphenazine vs. carbamezepine in the symptomatic treatment of diabetic neuropathy","volume":"27","author":"G\u00f3mez-P\u00e9rez","year":"1996","journal-title":"Arch Med Res"},{"key":"10.1016\/j.annder.2011.02.008_bib0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"9","author":"Dogra","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0165","first-page":"179","article-title":"Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study","volume":"5","author":"Harkins","year":"1991","journal-title":"J Craniomandib Disord"},{"key":"10.1016\/j.annder.2011.02.008_bib0170","first-page":"CD001133","article-title":"Anticonvulsant for acute and chronic pain (Review)","author":"Wiffen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2011.02.008_bib0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0180","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0185","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.annder.2011.02.008_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-3083.2000.00020.x","article-title":"Factors influencing pain outcome in herpes zoster: an observational study with valacyclovir","volume":"14","author":"Decroix","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.02.008_bib0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2011.02.008_bib0200","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","article-title":"Treatment of acute herpes zoster: effect of early (<48h) versus late (48\u201372h) therapy with acyclovir and valaciclovir on prolonged pain","volume":"178","author":"Wood","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2011.02.008_bib0205","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long-term follow-up","volume":"321","author":"Helgason","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2011.02.008_bib0210","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514260","article-title":"Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients","volume":"178","author":"Dworkin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2011.02.008_bib0215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0399-077X(98)80100-5","article-title":"Quelle doit \u00eatre la prise en charge th\u00e9rapeutique des patients atteints de zona\u00a0? Une revue de synth\u00e8se d\u2019essais randomis\u00e9s, contr\u00f4l\u00e9s et en double aveugle portant sur le traitement de la phase aigu\u00eb et des algies postzost\u00e9riennes","volume":"28","author":"Fouchard","year":"1998","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.annder.2011.02.008_bib0220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199403313301304","article-title":"A randomized trial of acyclovir for 7days or 21days with and without prednisolone for treatment of acute herpes zoster","volume":"330","author":"Wood","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","article-title":"Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial","volume":"125","author":"Whitley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5\u00a0% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0235","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/00003495-200464090-00002","article-title":"Review of lidocaine patch 5\u00a0% studies in the treatment of postherpetic neuralgia","volume":"64","author":"Davies","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.annder.2011.02.008_bib0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0091270002239817","article-title":"Safety and tolerability of the lidocaine patch 5\u00a0%, a targeted peripheral analgesic: a review of the literature","volume":"43","author":"Gammaitoni","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.annder.2011.02.008_bib0245","first-page":"CD004846","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia","author":"Khaliq","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2011.02.008_bib0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0190-9622(89)70171-7","article-title":"Topical capsaicin treatment of chronic postherpetic neuralgia","volume":"21","author":"Bernstein","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.02.008_bib0255","first-page":"510","article-title":"A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia","volume":"15","author":"Watson","year":"1993","journal-title":"Clin Ther"},{"key":"10.1016\/j.annder.2011.02.008_bib0260","first-page":"702","article-title":"NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain","volume":"10","author":"Noto","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.annder.2011.02.008_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3959(99)00007-X","article-title":"Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation","volume":"81","author":"Nolano","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.annder.2011.02.008_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/qjmed\/hci005","article-title":"Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study","volume":"98","author":"Kochar","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.annder.2011.02.008_bib0275","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.02.008_bib0280","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on immunization practices (ACIP) [published correction appears in MMWR Recomm Rep. 2008;57:779]","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:57:38Z","timestamp":1758970658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963811001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":56,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0151963811001335"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2011.02.008","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge symptomatique de la douleur neuropathique en dermatologie\u00a0: application aux algies postzost\u00e9riennes","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2011.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}